Comparative Effectiveness Multicenter Trial for Adhesion Characteristics of Ventral Hernia Repair Mesh

NCT ID: NCT01355939

Last Updated: 2015-02-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

173 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The proposed study will compare the benefits, harms, and comparative effectiveness of intraperitoneal barrier-coated and non-barrier coated ventral hernia repair (VHR) mesh in reducing adhesions, adhesion-related complications, and adhesiolysis sequelae in actual patient subpopulations and clinical circumstances. A subset of the data will be analyzed to compare the benefits, harms, and comparative effectiveness of the laparoscopic and open approaches to adhesiolysis. A comprehensive array of health-related risk factors and patient-centered outcomes will be assessed in the investigators diverse patient population for proper multivariate data analysis.

Specific Aim I: To evaluate and compare the adhesion characteristics of intraperitoneal barrier-coated versus non-barrier-coated mesh during abdominal re-exploration after prior ventral hernia repair.

Specific Aim II: To evaluate and compare the adhesion-related complications and adhesiolysis-related complications of intraperitoneal barrier-coated versus non-barrier-coated mesh during abdominal re-exploration after prior ventral hernia repair.

Specific Aim III: To determine the comparative effectiveness of intraperitoneal barrier-coated versus non-barrier-coated ventral hernia repair mesh in reducing adhesions, adhesion-related complications, and adhesiolysis sequelae in actual patient subpopulations and clinical circumstances.

Specific Aim IV: To evaluate and compare the adhesiolysis-related complications of the laparoscopic and open approaches to adhesiolysis during abdominal re-exploration after prior ventral hernia repair.

Specific Aim V: To determine the comparative effectiveness of the laparoscopic and open approaches to adhesiolysis during abdominal re-exploration after prior ventral hernia repair.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventral Hernia Adhesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Abdominal surgery after prior VHR with barrier-coated mesh

Clinically-Indicated Abdominal Re-Exploration Surgery

Intervention Type PROCEDURE

This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.

Abdominal surgery after prior VHR with nonbarrier-coated mesh

Clinically-Indicated Abdominal Re-Exploration Surgery

Intervention Type PROCEDURE

This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.

Lap adhesiolysis during abdominal surgery after prior VHR

Clinically-Indicated Abdominal Re-Exploration Surgery

Intervention Type PROCEDURE

This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.

Open adhesioloysis during abdominal surgery after prior VHR

Clinically-Indicated Abdominal Re-Exploration Surgery

Intervention Type PROCEDURE

This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinically-Indicated Abdominal Re-Exploration Surgery

This is a prospective observational study. Abdominal re-exploration surgery is clinically-indicated and planned as the standard of care for the patients regardless of their decision to participate in the study.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bard(TM) Mesh PROLENE(TM) ProLite(TM) ProLite(TM) Ultra(TM) Bard(TM) Soft Mesh PROLENE(TM) Soft Parietex(TM) Flat Sheet TEC INFINIT(TM) Mesh C-QUR Lite(TM) ULTRAPRO(TM) PROLENE(TM) Hernia System Bard(TM) Mesh PerFix Plug Bard(TM) Ventralex C-QUR(TM) Mesh PROCEED(TM) Bard(TM) Sepramesh(TM) IP Composite Parietex(TM) Composite PHYSIOMESH(TM) Bard(TM) Composix(TM) E/X Bard(TM) Composix(TM) L/P DUALMESH(R) DUALMESH(R) Plus VICRYL(TM) TIGR(R) Matrix Gore (R) Bio-A(R) AlloDerm(R) AlloMax(TM) FlexHD(R) Biodesign(TM) Surgisis(R) Strattice(TM) XenMatrix(TM) Veritas(R) SurgiMend(R) Peri-Guard(R) Permacol(TM) CollaMend(TM) FM CollaMend(TM)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* greater than or equal to 18 years of age
* prior ventral hernia repair with intraperitoneal placement of mesh (open or laparoscopic approach; absorbable barrier-coated mesh, permanent barrier-coated composite mesh, permanent barrier-coated noncomposite mesh, non-barrier-coated polypropylene mesh, or biologic mesh)
* subsequent abdominal procedure requiring exposure of entire surface area of intraperitoneal mesh

Exclusion Criteria

* less than 18 years of age
* inability to verify intraperitoneal mesh type or location
* active abdominal wound infection or open abdominal wound
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Atrium Medical Corporation

INDUSTRY

Sponsor Role collaborator

Washington University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Brunt, M.D.

Role: PRINCIPAL_INVESTIGATOR

Washington University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic Scottsdale

Phoenix, Arizona, United States

Site Status

University of California-San Diego

San Diego, California, United States

Site Status

Baystate Medical Center

Springfield, Massachusetts, United States

Site Status

Washington University

St Louis, Missouri, United States

Site Status

Mount Sinai Medical Center

New York, New York, United States

Site Status

Greenville Medical Center

Greenville, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1KM1CA156708-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2011-02112

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.